John Cox
7 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
The 3 newest of 7 trades
| Stock | Trade | Amount | Traded |
|---|---|---|---|
| Sell(10b5-1 plan) | $93K | Nov 13SEC filing | |
| Sell(10b5-1 plan) | $107K | Sep 8SEC filing | |
| Sell(10b5-1 plan) | $131K | Aug 13SEC filing |
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
John Cox's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 7 |
Alerts for John Cox
Use this page
How to cite
Breakaway, John Cox: CEO & President at Dyne Therapeutics (DYN), Nov 16, 2026, getbreakaway.com/insiders/john-cox
Journalists: email support@getbreakaway.com for the data behind this page.